Učitavanje...
IT-05 ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION
INTRODUCTION: Recurrent high grade glioma (rHGG) remains one of the most deadly cancers. Investigational agents Toca 511, a retroviral replicating vector, and Toca FC (extended-release 5-FC) are used in combination to target residual tumor at the time of resection. METHODS: This study (NCT01470794)...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218255/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|